Literature DB >> 23623639

Alphavirus structure: activation for entry at the target cell surface.

Marie-Christine Vaney1, Stéphane Duquerroy, Félix A Rey.   

Abstract

A wealth of new data about the 3D organization of alphavirus particles was obtained in the last few years. This includes the crystal structures of the envelope glycoprotein complexes at neutral and at acid pH, as well as electron microscopy reconstructions of intact virions at neutral pH to resolutions between 7Å and 4Å. The combination has provided unprecedented detail in the description of the alphavirus virion. This review surveys the main features discovered and the implications for the biology of the virus, in particular for the process of disassembly of the glycoprotein shell during entry. The major outstanding questions in this area are also identified and discussed.
Copyright © 2013 Elsevier B.V. All rights reserved.

Mesh:

Year:  2013        PMID: 23623639     DOI: 10.1016/j.coviro.2013.04.003

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  18 in total

1.  Imaging of the alphavirus capsid protein during virus replication.

Authors:  Yan Zheng; Margaret Kielian
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

2.  Residue-level resolution of alphavirus envelope protein interactions in pH-dependent fusion.

Authors:  Xiancheng Zeng; Suchetana Mukhopadhyay; Charles L Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

3.  Locking and blocking the viral landscape of an alphavirus with neutralizing antibodies.

Authors:  Jason Porta; Joyce Jose; John T Roehrig; Carol D Blair; Richard J Kuhn; Michael G Rossmann
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

4.  Attenuation of Getah Virus by a Single Amino Acid Substitution at Residue 253 of the E2 Protein that Might Be Part of a New Heparan Sulfate Binding Site on Alphaviruses.

Authors:  Ningning Wang; Xiaofeng Zhai; Xiaoling Li; Yu Wang; Wan-Ting He; Zhiwen Jiang; Michael Veit; Shuo Su
Journal:  J Virol       Date:  2022-01-05       Impact factor: 6.549

5.  Acidic pH-Induced Conformational Changes in Chikungunya Virus Fusion Protein E1: a Spring-Twisted Region in the Domain I-III Linker Acts as a Hinge Point for Swiveling Motion of Domains.

Authors:  Bibekananda Sahoo; Naresh Kumar Gudigamolla; Tirumala Kumar Chowdary
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

6.  Structural plasticity of the Semliki Forest virus glycome upon interspecies transmission.

Authors:  Max Crispin; David J Harvey; David Bitto; Camille Bonomelli; Matthew Edgeworth; James H Scrivens; Juha T Huiskonen; Thomas A Bowden
Journal:  J Proteome Res       Date:  2014-02-10       Impact factor: 4.466

7.  Near-germline human monoclonal antibodies neutralize and protect against multiple arthritogenic alphaviruses.

Authors:  Ryan J Malonis; James T Earnest; Arthur S Kim; Matthew Angeliadis; Frederick W Holtsberg; M Javad Aman; Rohit K Jangra; Kartik Chandran; Johanna P Daily; Michael S Diamond; Margaret Kielian; Jonathan R Lai
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-14       Impact factor: 11.205

8.  Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING Pathway.

Authors:  Bryan Gall; Kara Pryke; Jinu Abraham; Nobuyo Mizuno; Sara Botto; Tina M Sali; Rebecca Broeckel; Nicole Haese; Aaron Nilsen; Andrew Placzek; Thomas Morrison; Mark Heise; Daniel Streblow; Victor DeFilippis
Journal:  J Virol       Date:  2018-02-26       Impact factor: 6.549

Review 9.  Chikungunya Virus Vaccines: Platforms, Progress, and Challenges.

Authors:  Victor R DeFilippis
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.291

10.  Genome-wide RNAi screen identifies novel host proteins required for alphavirus entry.

Authors:  Yaw Shin Ooi; Katie M Stiles; Catherine Y Liu; Gwen M Taylor; Margaret Kielian
Journal:  PLoS Pathog       Date:  2013-12-19       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.